200 related articles for article (PubMed ID: 23102762)
41. Neospora GRA6 possesses immune-stimulating activity and confers efficient protection against Neospora caninum infection in mice.
Fereig RM; Shimoda N; Abdelbaky HH; Kuroda Y; Nishikawa Y
Vet Parasitol; 2019 Mar; 267():61-68. PubMed ID: 30878088
[TBL] [Abstract][Full Text] [Related]
42. Vaccine development against Neospora caninum infection.
Nishikawa Y; Mikami T; Nagasawa H
J Vet Med Sci; 2002 Jan; 64(1):1-5. PubMed ID: 11853138
[TBL] [Abstract][Full Text] [Related]
43. Quantitative analysis of parasite DNA in the blood of immunized and naïve mice after infection with Neospora caninum.
Pinitkiatisakul S; Mattsson JG; Lundén A
Parasitology; 2008 Feb; 135(2):175-82. PubMed ID: 17922929
[TBL] [Abstract][Full Text] [Related]
44. Development of two murine antibodies against Neospora caninum using phage display technology and application on the detection of N. caninum.
Dong J; Otsuki T; Kato T; Kohsaka T; Ike K; Park EY
PLoS One; 2013; 8(1):e53264. PubMed ID: 23308179
[TBL] [Abstract][Full Text] [Related]
45. A 78 kDa host cell invasion protein of Neospora caninum as a potential vaccine candidate.
Lv Q; Xing S; Gong P; Chang L; Bian Z; Wang L; Zhang X; Li J
Exp Parasitol; 2015 Jan; 148():56-65. PubMed ID: 25448355
[TBL] [Abstract][Full Text] [Related]
46. Establishment of Neospora caninum antigen-specific T cell lines of primarily CD4 T cells.
Tuo W; Davis WC; Fetterer R; Jenkins M; Boyd PC; Gasbarre LC; Dubey JP
Parasite Immunol; 2004 May; 26(5):243-6. PubMed ID: 15491474
[TBL] [Abstract][Full Text] [Related]
47. Identification of ribosomal phosphoprotein P0 of Neospora caninum as a potential common vaccine candidate for the control of both neosporosis and toxoplasmosis.
Zhang H; Lee EG; Liao M; Compaore MK; Zhang G; Kawase O; Fujisaki K; Sugimoto C; Nishikawa Y; Xuan X
Mol Biochem Parasitol; 2007 Jun; 153(2):141-8. PubMed ID: 17412435
[TBL] [Abstract][Full Text] [Related]
48. Identification of a gene cluster for cell-surface genes of the SRS superfamily in Neospora caninum and characterization of the novel SRS9 gene.
Risco-Castillo V; Marugán-Hernández V; Fernández-García A; Aguado-Martínez A; Jiménez-Ruiz E; Rodríguez-Marco S; Alvarez-García G; Ortega-Mora LM
Parasitology; 2011 Dec; 138(14):1832-42. PubMed ID: 21939586
[TBL] [Abstract][Full Text] [Related]
49. Blocking ELISA using recombinant NcSRS2 protein for diagnosing bovine neosporosis.
Sinnott FA; Monte LG; Collares TF; De Matos BM; Pacheco DB; Borsuk S; Andreotti R; Hartleben CP
Curr Microbiol; 2015 Mar; 70(3):429-32. PubMed ID: 25432863
[TBL] [Abstract][Full Text] [Related]
50. Mucosal immunization confers long-term protection against intragastrically established Neospora caninum infection.
Ferreirinha P; Correia A; Teixeira-Coelho M; Osório H; Teixeira L; Rocha A; Vilanova M
Vaccine; 2016 Dec; 34(50):6250-6258. PubMed ID: 27814932
[TBL] [Abstract][Full Text] [Related]
51. Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice.
Rojo-Montejo S; Collantes-Fernández E; Regidor-Cerrillo J; Rodríguez-Bertos A; Prenafeta A; Gomez-Bautista M; Ortega-Mora LM
Vet Parasitol; 2011 Feb; 175(3-4):220-9. PubMed ID: 21067865
[TBL] [Abstract][Full Text] [Related]
52. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice.
Zhang G; Huang X; Boldbaatar D; Battur B; Battsetseg B; Zhang H; Yu L; Li Y; Luo Y; Cao S; Goo YK; Yamagishi J; Zhou J; Zhang S; Suzuki H; Igarashi I; Mikami T; Nishikawa Y; Xuan X
Vaccine; 2010 Oct; 28(45):7243-7. PubMed ID: 20832493
[TBL] [Abstract][Full Text] [Related]
53. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.
Tuo W; Zhao Y; Zhu D; Jenkins MC
Vaccine; 2011 Mar; 29(13):2392-9. PubMed ID: 21281689
[TBL] [Abstract][Full Text] [Related]
54. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
[TBL] [Abstract][Full Text] [Related]
55. ELISAs based on rNcGRA7 and rNcSAG1 antigens as an indicator of Neospora caninum activation.
Hiasa J; Kohara J; Nishimura M; Xuan X; Tokimitsu H; Nishikawa Y
Vet Parasitol; 2012 Jul; 187(3-4):379-85. PubMed ID: 22365337
[TBL] [Abstract][Full Text] [Related]
56. Secretory Nanoparticles of
Suhaimi H; Hiramatsu R; Xu J; Kato T; Park EY
Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 30974883
[TBL] [Abstract][Full Text] [Related]
57. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.
Monney T; Debache K; Grandgirard D; Leib SL; Hemphill A
Vaccine; 2012 Oct; 30(46):6588-94. PubMed ID: 22940381
[TBL] [Abstract][Full Text] [Related]
58. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens.
Ramamoorthy S; Sanakkayala N; Vemulapalli R; Jain N; Lindsay DS; Schurig GS; Boyle SM; Sriranganathan N
Int J Parasitol; 2007 Nov; 37(13):1531-8. PubMed ID: 17575983
[TBL] [Abstract][Full Text] [Related]
59. Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms.
Pinitkiatisakul S; Mattsson JG; Wikman M; Friedman M; Bengtsson KL; Ståhl S; Lundén A
Vet Parasitol; 2005 Apr; 129(1-2):25-34. PubMed ID: 15817199
[TBL] [Abstract][Full Text] [Related]
60. Neospora caninum--how close are we to development of an efficacious vaccine that prevents abortion in cattle?
Reichel MP; Ellis JT
Int J Parasitol; 2009 Sep; 39(11):1173-87. PubMed ID: 19497326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
